Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 11,767	$ 10,308
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	905	250
Depreciation and amortization	1,579	1,652
Amortization of investment security premiums and accretion of discounts, net	1,553	939
Amortization of deferred loan costs	507	355
Amortization of core deposit intangible	153
Stock based compensation	41	97
Deferred gain on sale of premises	(387)	(387)
Gain on sale of other real estate owned	(20)
Equity in losses of real estate limited partnerships, net	1,222	846
Increase in cash surrender value of bank owned life insurance	(158)	(181)
Changes in assets and liabilities:
Net change in interest receivable	464	111
Net change in other assets	1,142	1,247
Net change in interest payable	(37)	(32)
Net change in other liabilities	1,427	841
Net cash provided by operating activities	20,158	16,046
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from maturities of investment securities available for sale	33,283	34,957
Proceeds from maturities of investment securities held to maturity	29,382	14,917
Purchases of investment securities available for sale	(45,403)	(112,892)
Loan originations in excess of principal payments	(63,887)	(76,020)
Purchases of Federal Home Loan Bank stock, net	(1,047)
Proceeds from sales of other real estate owned	92
Real estate limited partnership investments	(827)	(1,594)
Purchases of bank premises and equipment	(173)	(1,179)
Net cash used in investing activities	(48,580)	(141,811)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net change in deposits	(47,599)	78,701
Net increase in short-term borrowings	22,000
Net (decrease) increase in securities sold under agreement to repurchase	(10,556)	9,330
Principal payments on long-term debt	(1,565)	(62)
Cash dividends paid	(5,768)	(5,319)
Proceeds from the exercise of stock warrants	235
Increase in deferred compensation arrangements	430	215
Tax benefit from exercise of stock options and distribution of shares in deferred compensation arrangements	(221)	(100)
Net cash (used in) provided by financing activities	(43,044)	82,765
Decrease in cash and cash equivalents	(71,466)	(43,000)
Cash and cash equivalents beginning of period	150,183	154,459
Cash and cash equivalents end of period	78,717	111,459
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Total interest payments	3,432	3,079
Total income tax payments	1,122
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Distribution of stock under deferred compensation arrangements	559	514
Non-cash exercise of stock options and warrants	161	$ 626
Transfer of loans to other real estate owned	$ 60